Endothelial function and inflammation in coronary artery disease

D Tousoulis1, M Charakida, C Stefanadis

  • 1Cardiology Unit, Hippokration Hospital, Athens University Medical School, Athens, Greece. drtousoulis@hotmail.com

Insights

Endothelium and inflammation are key in atherosclerosis and cardiovascular events. Reducing inflammation and improving endothelial function may lower risks, but more trials are needed for targeted therapies in coronary artery disease.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Endothelial Biology

Background:

  • The endothelium and inflammatory processes play critical roles throughout all stages of atherosclerosis.
  • Clinical evidence highlights their prognostic value for ischemic events and outcomes post-acute coronary syndromes.

Purpose of the Study:

  • To review the role of endothelium and inflammation in atherosclerosis.
  • To assess the impact of interventions targeting these pathways on cardiovascular outcomes.
  • To determine the need for further randomized controlled trials (RCTs) on adjunctive therapies.

Main Methods:

  • Review of existing clinical studies and evidence.
  • Analysis of treatment strategies aimed at reducing inflammation and improving endothelial function.
  • Evaluation of the association between these interventions and cardiovascular event reduction.

Main Results:

  • Evidence confirms the central role of endothelium and inflammation in atherosclerosis.
  • Reductions in inflammatory markers and improved endothelial function correlate with decreased cardiovascular events.
  • Current data suggests potential benefit but lacks definitive proof from RCTs.

Conclusions:

  • Targeting endothelial dysfunction and inflammation shows promise for managing coronary artery disease.
  • Further randomized controlled trials are essential to validate drugs aimed at these pathways as adjunctive treatments.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Inflammation01:38

Inflammation

Overview
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...